Lactase clinical trials
How each study uses Lactase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Lactase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 2 |
| 2022 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 4
Eurofarma Laboratorios S.A. (2) · Aristotle University Of Thessaloniki (1) · Ain Shams University (1) · Muhammad Aamir Latif (1) · Vitacare Gmbh & Co. KG (1) · University of Pecs (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Lactase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)Not yet recruitingNot applicableUniversity of PecsNCT05100719Written as alverine-citrate + simethicone and lactase
- Lactase-Assisted Control Trial On Weight GAin in INfants.CompletedNot applicableAristotle University Of ThessalonikiNCT07150884Written as Lactase
- The Effect of Lactase-Treated Feeds on Feeding Intolerance in Preterm InfantsCompletedNot applicableAin Shams UniversityNCT07784062Written as Lactase enzyme
- Comparison of the Effectiveness of Oral Lactase Enzyme and Lactose Free FormulaCompletedNot applicableMuhammad Aamir LatifNCT06827405Written as Lactase enzyme
- A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to HypolactasiaCompletedPhase 3Eurofarma Laboratorios S.A.NCT01145586Written as Lactase Oral Tablets
- A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI)CompletedPhase 3Eurofarma Laboratorios S.A.NCT01145339Written as Lactase
- Acid Lactase in Combination With Yoghurt Bacteria for Improvement of Lactose Digestion in Lactose MalabsorbersCompletedNot applicableVitacare Gmbh & Co. KGNCT01593631Written as Acid lactase
As the comparator · 1 — what is tested is compared with Lactase
Codes
What other systems call Lactase · ClinicalTrials.gg INT008830
- MeSH (NLM) D043322LactaseOne source ClinicalTrials.gov
- UNII (FDA) 37515NWH9ULACTASEOne source FDA
- RxNorm 41397One source FDA
- NCI Thesaurus C29147LactaseOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D043322 | Lactase | One source ClinicalTrials.gov |
| UNII (FDA) | 37515NWH9U | LACTASE | One source FDA |
| RxNorm | 41397 | — | One source FDA |
| NCI Thesaurus | C29147 | Lactase | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.